News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Amol Akhade: How to manage rare GI cancers in 2025?
Amol Akhade/LinkedIn
Jan 28, 2025, 06:52

Amol Akhade: How to manage rare GI cancers in 2025?

Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics shared a post on LinkedIn:

“How to manage rare GI cancers in 2025?

Key takeaways for:

 Anal cancer

Amol Akhade

Appendix cancer

Amol Akhade

 

 

 Colorectal NET

Amol Akhade

 

Adenosquamous carcinoma of Colon

Amol Akhade

From American Society of Clinical Oncology (ASCO) GI25.”

More posts featuring Amol Akhade.

adenosquamous carcinoma Amol Akhade Anal Cancer Appendix Cancer ASCO cancer Colon Colorectal NET OncoDaily Oncology
Special Coverage
Science
Feb 26, 2025, 11:40
Jasmine Kamboj: Our patients are more than their cancer diagnoses
Blog
Feb 26, 2025, 11:15
Cristian Ochoa Arnedo: Vital Impact in the face of cancer
Science
Feb 26, 2025, 11:10
Bente Mikkelsen: How to Make the UN High-Level Meeting on NCDs Effective
Blog
Feb 26, 2025, 11:10
Andrea Necchi: A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment of RCC
Science
Feb 26, 2025, 11:05
Simrun Kaur-Rathore: The Role of 3D Printing and Augmented Reality in the Management of Hepatic Malignancies
Blog
Feb 26, 2025, 11:04
Mehezabin Dordi: Horizon - Looking Beyond Cancer with Strength
Blog
Feb 26, 2025, 10:59
Wafaa Rashed: Enhancing Public Awareness and Education of Genomic Research in Ghana
Science
Feb 26, 2025, 10:59
Elvina Almuradova: How GEMSTONE-303 differs from other trials
Oncolibrary
Feb 26, 2025, 10:54
New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience
Insight
Feb 26, 2025, 10:54
Pietro De Placido: The SURVIVE Study will challenge the "no symptoms, no scan" BC surveillance model
Insight
Feb 26, 2025, 10:50
Jarushka Naidoo: Mucinous lung adenocarcinomas - clinical features and outcomes
Blog
Feb 26, 2025, 10:49
Rizwan Jafri: Our annual Colon Cancer Awareness 5K event